Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease
Authors:
- 9 January 2022
- journal article
- research article
- Published by Massachusetts Medical Society in NEJM Evidence
- Vol. 1 (1)
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Myocardial infarction accelerates atherosclerosisNature, 2012
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host DiseaseNew England Journal of Medicine, 2011
- Circulating CD4 + CD25 hi CD127 lo Regulatory T-Cell Levels Do Not Reflect the Extent or Severity of Carotid and Coronary AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- B cell depletion reduces the development of atherosclerosis in miceJournal of Experimental Medicine, 2010
- Defective Circulating CD4+CD25+Foxp3+CD127low Regulatory T-cells in Patients with Chronic Heart FailureCellular Physiology and Biochemistry, 2010
- Inflammation in AtherosclerosisJACC, 2009
- Endothelial CD47 interaction with SIRPγ is required for human T-cell transendothelial migration under shear flow conditions in vitroBlood, 2008
- Altered status of CD4+CD25+ regulatory T cells in patients with acute coronary syndromesEuropean Heart Journal, 2006
- Natural regulatory T cells control the development of atherosclerosis in miceNature Medicine, 2006
- APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosisCell Death & Differentiation, 2001